Differential regulation of syndecan expression by osteosarcoma cell lines in response to cytokines but not osteotropic hormones

被引:28
作者
Birch, MA [1 ]
Skerry, TM [1 ]
机构
[1] Univ York, Dept Biol, York YO1 5DD, N Yorkshire, England
关键词
osteoblastic cells; syndecan; heparan sulfate proteoglycan (HSPG); cytokine; parathyroid hormone (PTH); 1,25(OH)(2)-vitamin D-3;
D O I
10.1016/S8756-3282(99)00088-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bone cells are regulated by interactions with both growth factors and components of the extracellular matrix (ECM), Syndecans are cell-surface heparan sulfate proteoglycans known to play a role in cell adhesion and migration, and binding of growth factors. This study was performed to investigate the expression of syndecans by osteoblasts. Reverse transcription-linked polymerase chain reaction (RT-PCR) and Northern analysis detected syndecan transcripts in the human osteosarcoma cell lines MG-63, TE-85, SaOS-2, and U2OS; human osteoblast-like cells; rat calvarial osteoblasts; and in human bone. Western blot analysis of proteoglycans from MG-63 and TE-85 cells detected multiple heparan sulfate proteoglycan core proteins consistent with syndecan expression, Regulation of syndecan-1, -2, and -4 expression was investigated in TE-85, MG-63, and SaOS-2 cells, in response to interleukin (IL)-1 beta, and IL-6, parathyroid hormone [PTH(1-34)], and 1,25(OH)(2)-vitamin D-3. Northern analysis demonstrated that in the osteosarcoma cell lines there was no regulation of syndecan transcript levels in response to PTH(1-34) or 1,25(OH)(2)-vitamin D-3 for 24 or 48 h. In contrast, when MG-63 and SaOS-2 cells were incubated with IL-1 beta (0.01-10 ng/mL) and IL-6 (0.1-50 ng/mL) there was a dose-dependent decrease in mRNA levels for syndecan-1 and 2 at 24 and 48 h, but in response to IL-1 beta upregulation in the levels of syndecan-4 transcripts, In addition, Northern analysis was performed on RNA isolated from neonatal rat calvarial osteoblasts cultured under conditions that promote osteogenesis for 0, 5, 13, 21, and 35 days. Syndecan-1 expression was observed to decrease during the culture period, syndecan-2 transcript levels increased, and there appeared to be no overall change in syndecan-4 levels. Controlled expression of syndecans by cells of the osteoblast lineage may be important in the regulation of osteoblastic proliferation and differentiation. (Bone 24:571-578; 1999) (C) 1999 by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:571 / 578
页数:8
相关论文
共 38 条
[31]   EFFECT OF TRANSFORMING GROWTH-FACTOR-BETA-1 AND BASIC FIBROBLAST GROWTH-FACTOR ON THE EXPRESSION OF CELL-SURFACE PROTEOGLYCANS IN HUMAN LUNG FIBROBLASTS - ENHANCED GLYCANATION AND FIBRONECTIN-BINDING OF CD44 PROTEOGLYCAN, AND DOWN-REGULATION OF GLYPICAN [J].
ROMARIS, M ;
BASSOLS, A ;
DAVID, G .
BIOCHEMICAL JOURNAL, 1995, 310 :73-81
[32]   Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican [J].
Steinfeld, R ;
VanDenBerghe, H ;
David, G .
JOURNAL OF CELL BIOLOGY, 1996, 133 (02) :405-416
[33]   Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation [J].
Subramanian, SV ;
Fitzgerald, ML ;
Bernfield, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (23) :14713-14720
[34]   ISOLATION AND CHARACTERIZATION OF PROTEOGLYCANS SYNTHESIZED BY MOUSE OSTEOBLASTIC CELLS IN CULTURE DURING THE MINERALIZATION PROCESS [J].
TAKEUCHI, Y ;
MATSUMOTO, T ;
OGATA, E ;
SHISHIBA, Y .
BIOCHEMICAL JOURNAL, 1990, 266 (01) :15-24
[35]   CELL-SURFACE PROTEOGLYCAN EXPRESSION CORRELATES WITH EPITHELIAL MESENCHYMAL INTERACTION DURING TOOTH MORPHOGENESIS [J].
THESLEFF, I ;
JALKANEN, M ;
VAINIO, S ;
BERNFIELD, M .
DEVELOPMENTAL BIOLOGY, 1988, 129 (02) :565-572
[36]  
VANIO S, 1992, DIFFERENTIATION, V50, P97
[37]  
WOODS A, 1994, MOL BIOL CELL, V5, P83
[38]   CELL-SURFACE, HEPARIN-LIKE MOLECULES ARE REQUIRED FOR BINDING OF BASIC FIBROBLAST GROWTH-FACTOR TO ITS HIGH-AFFINITY RECEPTOR [J].
YAYON, A ;
KLAGSBRUN, M ;
ESKO, JD ;
LEDER, P ;
ORNITZ, DM .
CELL, 1991, 64 (04) :841-848